Early molecular replication of human immunodeficiency virus type 1 in cultured-blood-derived T helper dendritic cells.

Por Langhoff, E, Kalland, K H, Haseltine, W A
Publicado em 1993

Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm.

Por Kalland, K H, Szilvay, A M, Langhoff, E, Haukenes, G
Publicado em 1994

Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutant...

Por Szilvay, A M, Brokstad, K A, Kopperud, R, Haukenes, G, Kalland, K H
Publicado em 1995

Comparative study of colony hybridization with synthetic oligonucleotide probes and enzyme-linked immunosorbent assay for identification of enterotoxigenic Escherichia coli.

Por Sommerfelt, H, Svennerholm, A M, Kalland, K H, Haukanes, B I, Bjorvatn, B
Publicado em 1988

The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.

Por Kalland, K H, Szilvay, A M, Brokstad, K A, Saetrevik, W, Haukenes, G
Publicado em 1994

Cloned polynucleotide and synthetic oligonucleotide probes used in colony hybridization are equally efficient in the identification of enterotoxigenic Escherichia coli.

Por Sommerfelt, H, Kalland, K H, Raj, P, Moseley, S L, Bhan, M K, Bjorvatn, B
Publicado em 1988

Cloned polynucleotide and synthetic oligonucleotide probes used in colony hybridization are equally efficient in the identification of Escherichia coli.

Por Sommerfelt, H, Kalland, K H, Raj, P, Moseley, S L, Bhan, M K, Bjorvatn, B
Publicado em 1990

Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures.

Por Langhoff, E, Terwilliger, E F, Bos, H J, Kalland, K H, Poznansky, M C, Bacon, O M, Haseltine, W A
Publicado em 1991

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

Por Engelsen, I B, Mannelqvist, M, Stefansson, I M, Carter, S L, Beroukhim, R, Øyan, A M, Otte, A P, Kalland, K H, Akslen, L A, Salvesen, H B
Publicado em 2008

High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

Por Mauland, K K, Trovik, J, Wik, E, Raeder, M B, Njølstad, T S, Stefansson, I M, Øyan, A M, Kalland, K H, Bjørge, T, Akslen, L A, Salvesen, H B
Publicado em 2011

High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors

Por Engerud, H, Tangen, I L, Berg, A, Kusonmano, K, Halle, M K, Øyan, A M, Kalland, K H, Stefansson, I, Trovik, J, Salvesen, H B, Krakstad, C
Publicado em 2014

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

Por Krakstad, C, Trovik, J, Wik, E, Engelsen, I B, Werner, H M J, Birkeland, E, Raeder, M B, Øyan, A M, Stefansson, I M, Kalland, K H, Akslen, L A, Salvesen, H B
Publicado em 2012

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer

Por Birkeland, E, Wik, E, Mjøs, S, Hoivik, E A, Trovik, J, Werner, H M J, Kusonmano, K, Petersen, K, Raeder, M B, Holst, F, Øyan, A M, Kalland, K-H, Akslen, L A, Simon, R, Krakstad, C, Salvesen, H B
Publicado em 2012

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

Por Salvesen, H. B., Carter, S. L., Mannelqvist, M., Dutt, A., Getz, G., Stefansson, I. M., Raeder, M. B., Sos, M. L., Engelsen, I. B., Trovik, J., Wik, E., Greulich, H., Bø, T. H., Jonassen, I., Thomas, R. K., Zander, T., Garraway, L. A., Øyan, A. M., Sellers, W. R., Kalland, K. H., Meyerson, M., Akslen, L. A., Beroukhim, R.
Publicado em 2009